시장보고서
상품코드
1663858

스마트 흡입기 시장 규모, 점유율, 성장 분석 : 유형별, 기술별, 적응증별, 최종사용자별, 유통별, 지역별 - 산업 예측(2025-2032년)

Smart Inhalers Market Size, Share, and Growth Analysis, By Type (Metered Dose Inhalers, Dry Powder Inhalers), By Technology (Bluetooth Enabled, Sensor Based), By Indication, By End User, By Distribution, By Region - Industry Forecast 2025-2032

발행일: | 리서치사: SkyQuest | 페이지 정보: 영문 219 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

스마트 흡입기 시장 규모는 2023년 151억 달러로 평가되며, 2024년 181억 8,000만 달러에서 2032년 802억 8,000만 달러로 예측 기간(2025-2032년) 동안 20.4%의 CAGR로 성장할 것으로 예상됩니다.

세계 스마트 흡입기 시장은 빠르게 성장하고 있으며, 천식 및 COPD와 같은 호흡기질환의 관리를 혁신적으로 변화시키고 있습니다. 센서와 블루투스 기술이 탑재된 스마트 흡입기는 약물 사용을 실시간으로 추적할 수 있어 환자의 순응도를 높이고 의료진이 치료 계획을 효과적으로 조정할 수 있도록 돕습니다. 주요 성장 촉진요인으로는 호흡기질환의 유병률 증가, 약물 순응도 향상에 대한 수요, 모니터링 기술의 발전 등이 있습니다. 높은 기기 비용과 제한적인 인지도라는 과제가 남아있지만, 전자 의료 기록 및 모바일 건강 애플리케이션과의 통합과 같은 추세는 시장 확대에 박차를 가할 것으로 보입니다. 결국, 스마트 흡입기는 병원 방문을 최소화하고 보다 개인화된 치료를 가능하게함으로써 비용 절감과 환자 치료 결과를 개선할 수 있는 큰 기회를 제공할 수 있습니다.

목차

소개

  • 조사 목적
  • 조사 범위
  • 정의

조사 방법

  • 정보 조달
  • 2차와 1차 데이터 방법
  • 시장 규모 예측
  • 시장 가정과 제한

주요 요약

  • 세계 시장 전망
  • 공급과 수요 동향 분석
  • 부문별 기회 분석

시장 역학과 전망

  • 시장 개요
  • 시장 규모
  • 시장 역학
    • 성장 촉진요인과 기회
    • 성장 억제요인과 과제
  • Porters 분석

주요 시장 인사이트

  • 핵심성공요인
  • 경쟁 정도
  • 주요 투자 기회
  • 시장 생태계
  • 시장 매력 지수(2024년)
  • PESTEL 분석
  • 거시경제 지표
  • 밸류체인 분석
  • 가격 분석

스마트 흡입기 시장 규모 : 유형별 & CAGR(2025-2032년)

  • 시장 개요
  • 정량 흡입기
  • 건조 분말 흡입기
  • 네블라이저

스마트 흡입기 시장 규모 : 기술별 & CAGR(2025-2032년)

  • 시장 개요
  • Bluetooth 대응
  • 센서 기반
  • 모바일 애플리케이션 통합

스마트 흡입기 시장 규모 : 적응증별 & CAGR(2025-2032년)

  • 시장 개요
  • 천식
  • 만성폐쇄성폐질환
  • 알레르기성 비염
  • 낭포성섬유증

스마트 흡입기 시장 규모 : 최종사용자별 & CAGR(2025-2032년)

  • 시장 개요
  • 병원
  • 재택 케어
  • 제약회사

스마트 흡입기 시장 규모 : 유통별 & CAGR(2025-2032년)

  • 시장 개요
  • 온라인 약국
  • 소매 약국
  • 병원

스마트 흡입기 시장 규모 : 지역별 & CAGR(2025-2032년)

  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 독일
    • 스페인
    • 프랑스
    • 영국
    • 이탈리아
    • 기타 유럽
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 한국
    • 기타 아시아태평양
  • 라틴아메리카
    • 브라질
    • 기타 라틴아메리카
  • 중동 및 아프리카
    • GCC 국가
    • 남아프리카공화국
    • 기타 중동 및 아프리카

경쟁 정보

  • 상위 5개사의 비교
  • 주요 기업의 시장 포지셔닝(2024년)
  • 주요 시장 기업이 채용한 전략
  • 최근의 시장 동향
  • 기업의 시장 점유율 분석(2024년)
  • 주요 기업 개요
    • 기업 상세
    • 제품 포트폴리오 분석
    • 기업 부문별 점유율 분석
    • 매출 전년비 비교(2022-2024년)

주요 기업 개요

  • Adherium Limited(New Zealand)
  • Aptar Group Inc.(Cohero Health Inc.)(USA)
  • AstraZeneca, Inc.(UK)
  • GlaxoSmithKline Plc.(UK)
  • Novartis AG(Switzerland)
  • OPKO Health Inc.(USA)
  • Philip Morris International Inc.(Vectura Group Plc)(USA/UK)
  • ResMed Inc.(Propeller Health)(USA)
  • Teva Pharmaceutical Industries Ltd.(Israel)
  • Boehringer Ingelheim International GmbH(Germany)
  • 3M Health Care Limited(USA)
  • Lupin Limited(India)
  • Findair Sp. z o.o.(Poland)
  • Inspiro Medical Ltd.(Israel)
  • Cognita Labs, LLC.(USA)
  • AireHealth Inc.(USA)
  • Zeolr Technologies Pvt Ltd.(India)
  • H&T Presspart Manufacturing Ltd.(Germany)

결론과 제안

ksm 25.04.03

Smart Inhalers Market size was valued at USD 15.1 billion in 2023 and is poised to grow from USD 18.18 billion in 2024 to USD 80.28 billion by 2032, growing at a CAGR of 20.4% during the forecast period (2025-2032).

The Global Smart Inhalers Market is experiencing rapid growth, transforming the management of respiratory diseases like asthma and COPD. Equipped with sensors and Bluetooth technology, smart inhalers enable real-time tracking of medication use, enhancing patient adherence and allowing healthcare providers to tailor treatment plans effectively. Key growth drivers include the rising incidence of respiratory conditions, the demand for better medication compliance, and advances in monitoring technologies. While challenges such as high device costs and limited awareness persist, trends like integration with electronic medical records and mobile health applications are poised to fuel market expansion. Ultimately, smart inhalers present significant opportunities for cost savings and improved patient outcomes by minimizing hospital visits and enabling more personalized care.

Top-down and bottom-up approaches were used to estimate and validate the size of the Smart Inhalers market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Smart Inhalers Market Segments Analysis

Global Smart Inhalers Market is segmented by Type, Technology, Indication, End User, Distribution and region. Based on Type, the market is segmented into Metered Dose Inhalers, Dry Powder Inhalers and Nebulizers. Based on Technology, the market is segmented into Bluetooth Enabled, Sensor Based and Mobile Application Integrated. Based on Indication, the market is segmented into Asthma, Chronic Obstructive Pulmonary Disease, Allergic Rhinitis and Cystic Fibrosis. Based on End User, the market is segmented into Hospital, Homecare and Pharmaceutical Companies. Based on Distribution, the market is segmented into Online Pharmacies, Retail Pharmacies and Hospitals. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Smart Inhalers Market

The rapid evolution of technology is a major catalyst for growth in the smart inhalers market. Innovations in advanced sensors, connectivity features, and data analytics have transformed how respiratory diseases are managed. Smart inhalers now possess the capability to gather and transmit crucial data regarding medication adherence, inhalation techniques, and environmental factors directly to healthcare providers in real-time. This facilitates personalized treatment approaches and enhances patient outcomes. For instance, Propeller Health has introduced a sensor-based smart inhaler system that attaches to regular inhalers, monitoring medication usage. The data is then relayed to a mobile application, which offers valuable insights and reminders, empowering patients and enabling healthcare providers to deliver tailored support.

Restraints in the Smart Inhalers Market

A significant restraint in the smart inhalers market is the higher price linked to these innovative devices when compared to traditional inhalers. The sophisticated technology and connectivity options integrated into smart inhalers result in elevated costs, which can hinder their adoption, especially in areas with constrained healthcare budgets and affordability issues. Prices for smart inhalers typically range from $100 to $300, influenced by brand and features. This financial barrier is particularly challenging for patients with limited financial means or insufficient insurance coverage, potentially slowing the uptake of smart inhalers in various markets and consequently impeding overall market growth.

Market Trends of the Smart Inhalers Market

The smart inhalers market is experiencing a significant trend with the integration of artificial intelligence (AI) and machine learning (ML) technologies, revolutionizing the management of respiratory diseases. These advanced algorithms analyze extensive datasets from smart inhalers, identifying usage patterns and providing predictive insights that enable healthcare providers to tailor treatment plans effectively. Companies like Cohero Health are at the forefront, utilizing AI and ML to combine inhaler usage data, environmental factors, and patient-specific information, allowing for real-time feedback and customized recommendations. This trend not only enhances patient engagement and compliance but also significantly improves clinical outcomes, positioning smart inhalers as a critical component of modern respiratory care.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis

Global Smart Inhalers Market Size by Type & CAGR (2025-2032)

  • Market Overview
  • Metered Dose Inhalers
  • Dry Powder Inhalers
  • Nebulizers

Global Smart Inhalers Market Size by Technology & CAGR (2025-2032)

  • Market Overview
  • Bluetooth Enabled
  • Sensor Based
  • Mobile Application Integrated

Global Smart Inhalers Market Size by Indication & CAGR (2025-2032)

  • Market Overview
  • Asthma
  • Chronic Obstructive Pulmonary Disease
  • Allergic Rhinitis
  • Cystic Fibrosis

Global Smart Inhalers Market Size by End User & CAGR (2025-2032)

  • Market Overview
  • Hospital
  • Homecare
  • Pharmaceutical Companies

Global Smart Inhalers Market Size by Distribution & CAGR (2025-2032)

  • Market Overview
  • Online Pharmacies
  • Retail Pharmacies
  • Hospitals

Global Smart Inhalers Market Size & CAGR (2025-2032)

  • North America (Type, Technology, Indication, End User, Distribution)
    • US
    • Canada
  • Europe (Type, Technology, Indication, End User, Distribution)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Type, Technology, Indication, End User, Distribution)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Type, Technology, Indication, End User, Distribution)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Type, Technology, Indication, End User, Distribution)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Adherium Limited (New Zealand)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Aptar Group Inc. (Cohero Health Inc.) (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AstraZeneca, Inc. (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GlaxoSmithKline Plc. (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Novartis AG (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • OPKO Health Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Philip Morris International Inc. (Vectura Group Plc) (USA/UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ResMed Inc. (Propeller Health) (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Teva Pharmaceutical Industries Ltd. (Israel)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boehringer Ingelheim International GmbH (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • 3M Health Care Limited (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Lupin Limited (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Findair Sp. z o.o. (Poland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Inspiro Medical Ltd. (Israel)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cognita Labs, LLC. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AireHealth Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Zeolr Technologies Pvt Ltd. (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • H&T Presspart Manufacturing Ltd. (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제